Literature DB >> 850859

The value of liver scan in the follow-up study of patients with adenocarcinoma of the colon and rectum.

B J Cedermark, S S Schultz, S Bakshi, K L Parthasarathy, A Mittelman, J T Evans.   

Abstract

Seventy consecutive patients with adenocarcinoma of the colon and rectum had a liver scan followed by surgical exploration of the liver. Preoperatively, blood chemistry studies were done in addition to palpation of the abdomen. Surgical findings were correlated to results of the liver scans, function tests and palpation of the liver. The overall concordance of liver scans with surgical findings was 78 per cent. Thirty per cent had false-positive results and 15 per cent, false-negative results. The correlation of the liver scan with surgical findings was improved with increasing extent of metastases. When less than 25 per cent of the liver was replaced by tumor, there was a random correlation of scan to surgical findings. By combining liver scans and liver function tests, metastases could be predicted with increased reliability only in patients who had severe metastatic disease of the liver. It is strongly recommended that patients with liver scans suggestive of metastatic disease and with most liver function tests within normal limits undergo exploration to establish the diagnosis. Exploratory laparotomy seems to be the only way to avoid chemotherapeutic treatment of patients with false-positive scans and still allow detection and treatment of metastases to the liver to occur at earlier stages.

Entities:  

Mesh:

Year:  1977        PMID: 850859

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  11 in total

1.  Liver function tests in patients with computed tomography demonstrated hepatic metastases.

Authors:  M D Ottmar; R L Gonda; K J Leithauser; O H Gutierrez
Journal:  Gastrointest Radiol       Date:  1989

2.  Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.

Authors:  U Metzger; B Mermillod; P Aeberhard; F Gloor; A Bissat; R Egeli; U Laffer; S Martinoli; W Mueller; R Schroeder
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  A prospective study of hepatic imaging in the detection of metastatic disease.

Authors:  T J Smith; M M Kemeny; P H Sugarbaker; A E Jones; M Vermess; T H Shawker; B K Edwards
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

4.  Prophylactic portal infusion chemotherapy as adjuvant therapy for the prevention of metachronous liver metastasis in colorectal cancer.

Authors:  O Kimura; K Kurayoshi; K Hoshino; A Sugezawa; M Makino; N Kaibara
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 5.  Intraportal chemotherapy for colorectal hepatic metastases.

Authors:  U T Laffer; U Metzger
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

6.  An assessment of ultrasound scanning in the recognition of colorectal liver metastases.

Authors:  G Lamb; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1982-11       Impact factor: 1.891

7.  Cannulation of the portal vein for cytotoxic liver perfusion in colorectal carcinomas: an alternative approach.

Authors:  T M Hunt; R Windle
Journal:  Ann R Coll Surg Engl       Date:  1987-01       Impact factor: 1.891

Review 8.  Studies on the treatment and prevention of colorectal liver metastases.

Authors:  I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1981-07       Impact factor: 1.891

9.  Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer.

Authors:  K Yoshida; T Fujikawa; G Yoshizawa; A Tanabea; K Sakurai
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

10.  Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Authors:  R H Taylor; J M Gilbert; M G Evans; H G Lane; P G Cassell
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.